91 related articles for article (PubMed ID: 26783937)
1. Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell.
Zhao J; Bai Z; Feng F; Song E; Du F; Zhao J; Shen G; Ji F; Li G; Ma X; Hang X; Xu B
Int J Biochem Cell Biol; 2016 Mar; 72():73-88. PubMed ID: 26783937
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.
Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL
Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666
[TBL] [Abstract][Full Text] [Related]
3. Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury.
Wang YG; Zhou JM; Ma ZC; Li H; Liang QD; Tan HL; Xiao CR; Zhang BL; Gao Y
Chem Biol Interact; 2012 Oct; 200(1):11-20. PubMed ID: 22982774
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
Masuyama H; Nakamura K; Nobumoto E; Hiramatsu Y
Int J Oncol; 2016 Sep; 49(3):1211-20. PubMed ID: 27572875
[TBL] [Abstract][Full Text] [Related]
5. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells.
Warnecke C; Zaborowska Z; Kurreck J; Erdmann VA; Frei U; Wiesener M; Eckardt KU
FASEB J; 2004 Sep; 18(12):1462-4. PubMed ID: 15240563
[TBL] [Abstract][Full Text] [Related]
6. Correlation study showing no concordance between EPAS-1/HIF-2alpha mRNA and protein expression in transitional cellcancer of the bladder.
Ji P; Xuan JW; Onita T; Sakai H; Kanetake H; Gabril MY; Sun Y; Moussa M; Chin JL
Urology; 2003 Apr; 61(4):851-7. PubMed ID: 12670588
[TBL] [Abstract][Full Text] [Related]
7. Intracellular localization of pregnane X receptor in HepG2 cells cultured by the hanging drop method.
Yokobori K; Kobayashi K; Azuma I; Akita H; Chiba K
Drug Metab Pharmacokinet; 2017 Oct; 32(5):265-272. PubMed ID: 28942083
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity.
Elias A; Wu J; Chen T
Mol Pharmacol; 2013 Jun; 83(6):1229-36. PubMed ID: 23536728
[TBL] [Abstract][Full Text] [Related]
9. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells.
Smutny T; Bitman M; Urban M; Dubecka M; Vrzal R; Dvorak Z; Pavek P
Arch Toxicol; 2014 Dec; 88(12):2243-59. PubMed ID: 24819614
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L
Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
Mol Pharmacol; 2007 Oct; 72(4):1045-53. PubMed ID: 17636047
[TBL] [Abstract][Full Text] [Related]
12. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
[TBL] [Abstract][Full Text] [Related]
13. Cardiac expressions of HIF-1 alpha and HLF/EPAS, two basic loop helix/PAS domain transcription factors involved in adaptative responses to hypoxic stresses.
Ladoux A; Frelin C
Biochem Biophys Res Commun; 1997 Nov; 240(3):552-6. PubMed ID: 9398602
[TBL] [Abstract][Full Text] [Related]
14. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss).
Wassmur B; Gräns J; Kling P; Celander MC
Aquat Toxicol; 2010 Oct; 100(1):91-100. PubMed ID: 20719396
[TBL] [Abstract][Full Text] [Related]
15. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α.
Guo X; Tian Z; Wang X; Pan S; Huang W; Shen Y; Gui Y; Duan X; Cai Z
Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):106-13. PubMed ID: 25520177
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pregnane X receptor (PXR) function and UGT1A1 gene expression by posttranslational modification of PXR protein.
Sugatani J; Uchida T; Kurosawa M; Yamaguchi M; Yamazaki Y; Ikari A; Miwa M
Drug Metab Dispos; 2012 Oct; 40(10):2031-40. PubMed ID: 22829544
[TBL] [Abstract][Full Text] [Related]
18. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
19. Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes.
Roth A; Looser R; Kaufmann M; Meyer UA
Pharmacogenet Genomics; 2008 Apr; 18(4):325-37. PubMed ID: 18334917
[TBL] [Abstract][Full Text] [Related]
20. miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway.
Shao QP; Wei C; Yang J; Zhang WZ
Onco Targets Ther; 2020; 13():7213-7227. PubMed ID: 32801751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
